media – Page 572 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

IoT devices vulnerable to Spectre and Meltdown exploitation

Healthcare organizations should use risk management processes to ensure the security of health information and protect against the vulnerabilities stemming from the Spectre and Meltdown threats.
- Source: Healthcare IT News
- 520
- January 23, 2018
healthcare technology Internet of Things Market Views medical device
Diagnostic Products of the Future

Panelists at the recent J.P. Morgan Healthcare Conference in San Francisco, CA were charged with separating the hype from the reality in the field of diagnostics and offered insight into what products will win in the space.
- Source: MDDI Online
- 776
- January 23, 2018
diagnostics healthcare technologies and innovations medical device Researches
Digital currency-based fitness app Sweatcoin lands $5.7M in funding

Earning a little extra toward workout products and fitness classes could be as easy as tracking the steps you take outside. London-based Sweatcoin, a company which “pays” users a digital currency based on their daily steps, has just landed $5.7 million in a funding round led by Goodwater Capital with participation from Seedcamp, Greylock Partners, Rubylight, SmartHub, and several angel investors.
- Source: Mobile Health News
- 652
- January 23, 2018
blockchain Company Insight digital health mHealth
Pandion Therapeutics Announces $58 Million Series A Financing to Advance Tissue-Specific Immune Modulator Drugs

Pandion Therapeutics, Inc., a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation, today announced the completion of a $58 million Series A financing. This funding will be used to advance its initial drug programs for autoimmune and inflammatory diseases toward the clinic, as well as to continue building the company’s technology platform and pipeline. Polaris Partners, the founding investor that provided the initial seed funding, co-led the Series A financing along with Versant Ventures and Roche Venture Fund. SR One and BioInnovation Capital also participated in the round.
- Source: finance.yahoo
- 900
- January 22, 2018
antibody Company Insight immunomodulation
Adlai Nortye Enters into Global Licensing Agreement with Eisai for EP4 Antagonist

Adlai Nortye Biopharma Co., Ltd. (NEEQ: 870946) ("Adlai Nortye" or "the Company"), a biopharmaceutical company dedicated to discovery and commercialization of new and effective drugs, announced today that it had entered into a Global Licensing Agreement ("the Agreement") with Eisai Co., Ltd. ("Eisai"), a global pharmaceutical company with a focus on serving patients with unmet medical needs.
- Source: Prnewswire
- 769
- January 22, 2018
biopharmaceutical EP4 antagonist Market Views
Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to advance public health measures.
- Source: medicalxpress
- 675
- January 22, 2018
smallpox synthetic DNA synthetic virus vaccine
Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers

Findings In this population-based cohort study of more than 100, 000 predominantly postmenopausal women, risk reductions for ovarian cancer associated with increasing duration of oral contraceptive use were generally consistent across health behaviors. For endometrial cancer, the reductions were strongest among current smokers, obese women, and those who exercised rarely; lack of associations with breast and colorectal cancer were consistent across health behaviors.
- Source: Jamanetwork
- 515
- January 22, 2018
cancer oral contraceptive use Researches
FDA to expedite release of recall information

When the FDA identifies that a product it regulates violates the law, it protects the public by working with the manufacturer and distributors to facilitate the product’s recall (i.e., removal from the marketplace or product correction). Among other actions, FDA assures that the public is warned when products present the most significant public hazards, including those recalls associated with an outbreak.
- Source: Mass Device
- 652
- January 22, 2018
Consumer Healthcare FDA Policy
Functionality, usability cited as barriers to adoption of caregiver digital health tools in AARP report

In 2014, research by the AARP estimated that 40 million Americans provide unpaid care to an adult. About 68 percent of family caregivers have no paid help and by 2020, 45 million family caregivers will care for 117 million people, according to a new report on caregivers that is part of AARP’s Project Catalyst.
- Source: MedCity News
- 594
- January 22, 2018
healthcare Home medical equipment Researches
The Top 8 Technologies Combating Food Allergy

Food allergy has been referred to as the second wave of the allergy epidemic, asthma being the first.
- Source: Medical Futurist
- 929
- January 22, 2018
Allergies Company Insight digital health healthcare technology mHealth

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.